Rockshelter Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-47,430
Closed -$9.72M 36
2017
Q3
$9.72M Sell
47,430
-3,042
-6% -$707K 3.08% 15
2017
Q2
$12.3M Buy
50,472
+323
+0.6% +$75.9K 3.74% 10
2017
Q1
$12M Buy
50,149
+188
+0.4% +$43.8K 3.61% 14
2016
Q4
$10.5M Buy
49,961
+13,116
+36% +$2.72M 3.28% 16
2016
Q3
$8.49M Buy
36,845
+3,529
+11% +$862K 2.95% 18
2016
Q2
$7.7M Buy
+33,316
New +$7.68M 2.65% 18

Other funds holding AGN

Rockshelter Capital Management's AGN Position: Q4 2017 in Review

Rockshelter Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 47,430 shares — an estimated $9.72M sold.

Rockshelter Capital Management first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $12.3M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Rockshelter Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Rockshelter Capital Management sold 47,430 Allergan plc shares in Q4 2017, an estimated $9.72M.
  • Rockshelter Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Rockshelter Capital Management's Allergan plc position peaked at $12.3M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Rockshelter Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.